The Guardant360 assay kits
The Guardant360 assay kits are required to deliver the Trust's partnership agreement with Guardant Health. This is the only kit that can be used to deliver this and is included in the contract requirements with Guardant.
Buyer
The Royal Marsden NHS Foundation Trust
Value
£1,638,336
Published
8 Jun 2022
Closes
8 Jun 2022
Procurement details
Source
Find a Tender
Region
Kensington & Chelsea and Hammersmith & Fulham
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33910000
Pathology dissection instruments and supplies
Lots
Lot 1 The Guardant360 assay kits
£1,638,336
The G360 assay designed by Guardant Health is run using Guardant's proprietary sequencing reagents and bioinformatics pipeline and as such an alternative sequencing assay cannot be used. This is direct award to Guardant Health due to designed kits which are needed to run the Guardant assay.
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.